Portland-based biotech ImmuCell posts 45% sales increase for Q4

February 28, 2022

(From Mainebiz) ImmuCell recently posted significant sales increases for 2021. The Portland-based biotech company manufactures health products for cattle and is developing a treatment for a dairy cow disease. In 2020, ImmuCell received a $500,000 loan from MTI to help bolster production.

Read more here.